Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors - Wikidata - wikimedia - TriplyDB

Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors

Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors

http://www.wikidata.org/entity/Q35286762

about

Contribution of toll-like receptor signaling pathways to breast tumorigenesis and treatment Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis Toll-like receptor 9 in breast cancer.Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients Tumor infiltrating CD8(+) T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinoma Toll-like receptors as novel therapeutic targets for ovarian cancer.Whole blood expression profiling from the TREAT trial: insights for the pathogenesis of polyarticular juvenile idiopathic arthritis Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling.Biopathological Significance of TLR9 Expression in Cancer Cells and Tumor Microenvironment Across Invasive Breast Carcinomas Subtypes.Exogenous or endogenous Toll-like receptor ligands: which is the MVP in tumorigenesis?Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.Toll-like receptor agonists: current status and future perspective on their utility as adjuvants in improving anticancer vaccination strategies.Estrogen receptor-α and sex steroid hormones regulate Toll-like receptor-9 expression and invasive function in human breast cancer cells.Cell membrane and intracellular expression of toll-like receptor 9 (TLR9) in colorectal cancer and breast cancer cell-lines.Cancer-associated toll-like receptor modulation and insinuation in infection susceptibility: association or coincidence?Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer.Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer.Impact of viral and host DNA methylations on HPV16-related cervical cancer pathogenesis.Hypoxia regulates Toll-like receptor-9 expression and invasive function in human brain cancer cells in vitro.Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis.

P2860

Q26825259-5FB9A37C-C568-4D5F-9BF8-B010F91EB427 Q26861234-94017DD2-DA8B-4428-ADE2-337C9D537D2E Q33762632-BFC34DDB-2D44-47D0-880A-7188F626A118 Q33928402-4222A5E6-40E8-431B-90E6-86FA34B38EBA Q34698854-6F8B81CA-3694-4E0D-9B08-3E9B3A4D8DC5 Q35241051-867F63A2-081F-46B7-839E-F847D62FC4C4 Q35653787-1E63F7AD-C7F0-41F8-9A29-C4E37A9C31AB Q35798941-BE0868BC-7B9C-48D2-9325-CDA5559130D5 Q35864309-B133C4A6-E34E-43BA-AC8E-5952EA22DE78 Q37073220-11218155-4767-4868-AFA0-DA03D1168607 Q37575463-C7E9E1D0-0308-4B84-AB0C-71BDBD136041 Q37605221-2F2EA546-9230-4D56-8377-2F2257E00E20 Q37952071-C532474D-4EA6-4B34-A98A-5336482621D0 Q38039958-7554B1E6-0BB2-4368-BE7D-61AB7A6F1920 Q38103581-A139357B-0121-4D6C-833A-0E1019175E8A Q38410178-A7A12E03-7206-41AB-82F7-AB42E0AAF838 Q38720388-2A25D728-3E8A-4F2C-924E-B0C5CCB19BDE Q38727874-E33CFE3D-3719-4EEA-8795-DF8E3FC80A99 Q39115582-D59D733A-01C3-4FBB-8CF6-2F7F51844B0F Q39305431-1173CA3C-BD68-44C0-8C2E-EB9116321F8D Q40220618-70BD9035-482B-463C-AF8F-80B1D5FC9E48 Q40893702-A30923F1-9D20-4913-9770-4A586293ADFA Q41497232-5BF17176-FFFB-4E41-BB69-BDB0C17C73B7 Q52726017-58DE3542-922C-41C8-B00A-70C4AC2520F2

P2860

Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors

http://www.wikidata.org/entity/Q35286762

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Toll-like receptor 9 expressio ...... h poorly differentiated tumors

@ast

Toll-like receptor 9 expressio ...... h poorly differentiated tumors

@en

type

label

Toll-like receptor 9 expressio ...... h poorly differentiated tumors

@ast

Toll-like receptor 9 expressio ...... h poorly differentiated tumors

@en

prefLabel

Toll-like receptor 9 expressio ...... h poorly differentiated tumors

@ast

Toll-like receptor 9 expressio ...... h poorly differentiated tumors

@en

P1433

Q35286762-22253231-0905-4329-9ACF-0C405127469C

P1476

Q35286762-A525D413-6E4A-4936-B243-1FAA269AE6F2

P2093

Q35286762-01848D08-F171-4F30-B264-DA511A86B2E7

Q35286762-2F319255-8A94-4914-A4FC-15DFDF6E967D

Q35286762-5710E048-DB4F-48DB-B5CB-980190A1C5A8

Q35286762-5D5FCEF5-05D8-4EB7-B7FD-65564C327D76

Q35286762-5E0B2546-21D2-4216-941C-21FB06E46473

Q35286762-827A7450-9B89-4DC1-B208-7F0C46465B1C

Q35286762-856A5763-A4C3-4CFD-B8E4-151CB0ACD040

Q35286762-ACCA5E37-CA52-40D1-B814-F72A626502F4

Q35286762-BDA9D8BD-2C2E-4113-8D77-F44878CC1CF8

Q35286762-CA09EA71-D38C-4FD3-8A36-B303E1FF12DF

P2860

Q35286762-02F0CB81-179C-49FC-B48A-2D9F7A9D1610

Q35286762-0DA913B8-6AFE-4549-A0F0-B1FD0E3D26E8

Q35286762-0E5A0A71-25A0-4591-94E9-9AED6210AE59

Q35286762-10AA8482-9296-4E28-AC7A-8BF96E036298

Q35286762-15543003-0A97-49FD-8B59-2C8AF57DBAAC

Q35286762-1A0FE84B-ED41-4C75-91AF-7450F24F0851

Q35286762-314BEA98-7326-45E6-A55D-DC56EB398F75

Q35286762-448347DE-68A0-41A6-8507-E8FDE7B8AA89

Q35286762-553310D9-BF65-4D59-A986-B609C94D1498

Q35286762-5C59A3FA-7479-42A0-ABBD-725701183192

P304

Q35286762-2BF4BCAD-C769-4D5A-9407-A66747AF1C57

P31

Q35286762-F1C4B5C7-FCBC-4938-88B0-624201082E5C

P356

Q35286762-6114B52C-D3A1-4959-902A-82C6A87FA4C3

P433

Q35286762-135C34A8-86C4-4D84-8DCC-ADF4AC9127FB

P478

Q35286762-12B59C00-8445-4755-A4D9-05B3E8FA1B17

P50

Q35286762-4411C55A-DF8C-455E-BBB5-714AD1D4295E

Q35286762-5FB13A5F-6CDF-46A1-A8BE-8C562DFC717C

Q35286762-8CD5D21C-9324-49C5-8AE5-A7DB4854A4B3

P577

Q35286762-DEE1C8FE-A8A7-4F59-9618-42DFF5DAAE29

P5875

Q35286762-A8F29E9A-A625-4765-861F-CC6C7B947CB8

P698

Q35286762-B44821BE-0E92-4A14-AEFC-6BF3F6D8D429

P921

Q35286762-7D488DE7-410F-4AFA-89E0-AF7ACF084A10

Q35286762-AF123287-8B3C-48EA-B720-C48B481B0EB1

P932

Q35286762-6B3FD116-6FFB-4430-9CB3-E4E367D49057

P356

J.1349-7006.2010.01491.X

P1433

P1476

Toll-like receptor 9 expressio ...... h poorly differentiated tumors

@en

P2093

Allison Jones

http://www.w3.org/2001/XMLSchema#string

Cornelia Hauser-Kronberger

http://www.w3.org/2001/XMLSchema#string

Daniel Egle

http://www.w3.org/2001/XMLSchema#string

Daniel Reimer

http://www.w3.org/2001/XMLSchema#string

Elisabeth Müller-Holzner

http://www.w3.org/2001/XMLSchema#string

Georg Goebel

http://www.w3.org/2001/XMLSchema#string

Petra Obexer

http://www.w3.org/2001/XMLSchema#string

Regina Berger

http://www.w3.org/2001/XMLSchema#string

Roland Reitsamer

http://www.w3.org/2001/XMLSchema#string

Wolfgang Doppler

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of repetitive element DNA methylation by MethyLight.

FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells

Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9

In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro

Hypomethylation distinguishes genes of some human cancers from their normal counterparts

Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes

DNA methylation in cancer: too much, but also too little.

The 5-methylcytosine content of DNA from human tumors.

Immunotherapeutic uses of CpG oligodeoxynucleotides.

DNA hypomethylation is prevalent even in low-grade breast cancers.

P304

1059-1066

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1349-7006.2010.01491.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Michael J Ausserlechner

M Widschwendter

P577

2010-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41434655

http://www.w3.org/2001/XMLSchema#string

P698

20156214

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

3188854

http://www.w3.org/2001/XMLSchema#string